PTEN suppresses oncogenic signaling for prostate cancer through dephosphorylation of PTK6 tyrosine 342(PY342), and PTK6 facilitates cell migration and proliferation by phosphorylating Esp8 [48]. This evidence concerns the gene PTK6 and prostate carcinoma.